NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
30.67
-0.03 (-0.10%)
Oct 3, 2025, 4:00 PM EDT - Market closed
NAMS Market Cap
NAMS has a market cap or net worth of $3.45 billion as of October 3, 2025. Its market cap has increased by 140.59% in one year.
Market Cap
3.45B
Enterprise Value
2.67B
1-Year Change
140.59%
Ranking
Category
Stock Price
$30.67
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $3.45B, an increase of 2,136.54%. That is a compound annual growth rate of 95.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 3.45B | 25.55% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | 154.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |